FY2021 NIH awards · Principal investigators
Neurosurgery at University of Florida
Gainesville, FL
Funding
$13.1M
$13,074,940
Awards
18
FY2021 NIH awards in Neurosurgery
Principal investigators
14
14 lead a grant here, 0 co-investigators
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Neurosurgery row of the University of Florida page.
Leads a grant in this department
14 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Chimowitz, Marc Ivor
Leads 1 award · $8,624,024
- 1U01NS117450-01A1Department: NIH department codeComparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis$8,624,024award amount
Disney, Matthew D
Leads 2 awards · $1,402,999
- 6R35NS116846-03Department: NIH department codeDesign of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology$725,374award amount
- 6P01NS099114-06Department: NIH department codePathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways$677,625award amount
Flores, Catherine T
Leads 2 awards · $667,188
- 5R01NS111033-02Department: NIH department codeHematopoietic stem cells overcome treatment resistance to PD-1 blockade against brain tumors$333,594award amount
- 5R01NS112315-03Department: NIH department codeHematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas$333,594award amount
Tran, David D
Leads 1 award · $543,700
- 5R01CA238387-02Department: NIH department codeNovel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$543,700award amount
Sayour, Elias
Leads 1 award · $472,806
- 1R37CA251978-01A1Department: NIH department codeOvercoming the blood-brain barrier with nanoparticle vaccines against gliomas$472,806award amount
Hoh, Brian Lim
Leads 1 award · $357,207
- 5R01NS110710-02Department: NIH department codeInflammatory Mediators and Mechanisms of Cerebral Aneurysm Formation and Rupture$357,207award amount
Rahman, Maryam
Leads 3 awards · $343,980
- 5K08NS099484-05Department: NIH department codeLeveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma$181,980award amount
- 3K08NS099484-05S2Department: NIH department codeLeveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma$108,000award amount
- 3K08NS099484-05S1Department: NIH department codeLeveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma$54,000award amount
Deleyrolle, Loic Pierre
Leads 1 award · $190,625
- 1R21NS116578-01A1Department: NIH department codeSlow cycling cell RNA based T cell therapy to prevent recurrence in GBM$190,625award amount
Rumbaugh, Gavin R
Leads 1 award · $175,400
- 6R01MH125187-03Department: NIH department codeMolecular and cellular basis for autism spectrum disorders caused by exacerbated translation$175,400award amount
Rader, Christoph
Leads 1 award · $114,593
- 6R21CA263240-02Department: NIH department codeT-cell engaging bispecific antibodies designed for proteolytic activation in the tumor microenvironment$114,593award amount
Von Roemeling, Christina Anna Elizabeth
Leads 1 award · $65,994
- 1F32CA257098-01Department: NIH department codeTargeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma$65,994award amount
Sebastian, Mathew
Leads 1 award · $47,077
- 5F30CA232641-04Department: NIH department codePglyrp3 cooperates with Snail1 to mediate anti-tumor immune response in breast cancer$47,077award amount
Francis, Connor Patrick
Leads 1 award · $41,033
- 1F30CA260911-01Department: NIH department codeThymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$41,033award amount
Dyson, Kyle
Leads 1 award · $28,314
- 5F30CA221345-05Department: NIH department codeImmunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$28,314award amount